Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | CT7439 |
| Synonyms | |
| Therapy Description |
CT7439 is a CDK12/13 inhibitor, which may have antitumor activity (J Clin Oncol, 41, no. 16_suppl (2023) 5546). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| CT7439 | CT-7439|CT 7439 | CDK12 Inhibitor 4 | CT7439 is a CDK12/13 inhibitor, which may have antitumor activity (J Clin Oncol, 41, no. 16_suppl (2023) 5546). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06600789 | Phase Ib/II | CT7439 | A Modular Phase 1/2 Study with CT7439 in Participants with Solid Malignancies | Recruiting | USA | GBR | 0 |